Solesence (SLSN) Common Equity (2010 - 2026)

Solesence has reported Common Equity for 17 years, with the latest figure at $17.0 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 11.95% year-over-year to $17.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.0 million (up 11.95% YoY), and the FY2025 full-year result was $17.6 million, up 17.98% from the prior year.
• Common Equity for Q1 2026 stood at $17.0 million, down from $17.6 million in the prior quarter.
• The five-year high for Common Equity was $18.2 million in Q2 2025, with the low at $1.9 million in Q4 2023.
• Historically, Common Equity has averaged $10.4 million across 5 years, with a median of $8.0 million in 2022.
• Annual changes were most pronounced in 2023 — Common Equity plunged 66.33% — and 2024, when it jumped 685.8%.
• Solesence's Common Equity stood at $5.6 million in 2022, then slumped by 66.33% to $1.9 million in 2023, then jumped by 685.8% to $14.9 million in 2024, then gained by 17.98% to $17.6 million in 2025, then dropped by 3.78% to $17.0 million in 2026.
• The last three Common Equity figures came in at $17.0 million (Q1 2026), $17.6 million (Q4 2025), and $17.2 million (Q3 2025), per Business Quant data.